The SINS trial: A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma
<p>Abstract</p> <p>Background</p> <p>Basal cell carcinoma is the commonest human cancer. Despite increasing incidence it remains poorly researched. While not life threatening it can cause significant cosmetic disfigurement. Imiquimod, a cream which enhances the body...
Main Authors: | Armstrong Sarah J, Williams Hywel C, Ozolins Mara, Bath-Hextall Fiona J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-04-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/11/1/42 |
Similar Items
-
Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
by: Gamze Ozturk Karabulut, et al.
Published: (2017-01-01) -
Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases Tratamento tópico do carcinoma basocelular superficial e nodular pelo imiquimod creme a 5%: observação de 10 casos
by: Cyro Festa Neto
Published: (2002-12-01) -
Imiquimod 5% cream in topical treatment of facial basal cell carcinoma
by: Grubor Svetlana D., et al.
Published: (2015-01-01) -
Disseminated Superficial Actinic Porokeratosis on the Face Treated with Imiquimod 5% Cream
by: Hassan Riad, et al.
Published: (2013-10-01) -
Management of superficial basal cell carcinoma: focus on imiquimod
by: Beverly Raasch
Published: (2009-06-01)